Product Information
PREDNISOLONE AC 1% EYE DROP is a generic product labeled by Pacific Pharma, Inc., priced at $4.7221 per ML under NDC 60758011910. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
60758011910
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PREDNISOLONE ACETATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017011FDA Approved
Before 1982
TE Code
AB
On Market Since
8/19/1997
Pharmacological Classes
Price Statistics
The NADAC for PREDNISOLONE AC 1% EYE DROP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 22.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7221 per ML |
|---|---|
| All-time high | $9.1363 (Apr 16, 2014) |
| All-time low | $4.0412 (Nov 20, 2024) |
| 52-week high | $4.7221 |
| 52-week low | $4.2091 |
| Median price | $6.2220 |
| Average price | $6.4000 |
| Largest weekly change | +47.4% (Dec 18, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
prednisolone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREDNISOLONE AC 1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for PREDNISOLONE AC 1% EYE DROP, manufactured by Pacific Pharma, Inc., is $4.7221 per ML (NDC 60758011910), effective Sep 30, 2026.
How has the price of PREDNISOLONE AC 1% EYE DROP changed over time?
Over the history we have for it, the NADAC for PREDNISOLONE AC 1% EYE DROP has declined 22.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREDNISOLONE AC 1% EYE DROP?
Since Nov 28, 2013, the NADAC for PREDNISOLONE AC 1% EYE DROP has ranged from a low of $4.0412 (Nov 20, 2024) to a high of $9.1363 (Apr 16, 2014), with a median of $6.2220 per ML.
Are there cheaper alternatives to PREDNISOLONE AC 1% EYE DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREDNISOLONE AC 1% EYE DROP, is $4.4557 per ML — about 6% below PREDNISOLONE AC 1% EYE DROP.
Who manufactures PREDNISOLONE AC 1% EYE DROP?
PREDNISOLONE AC 1% EYE DROP (NDC 60758011910) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.